tech
The Palantir controversy is a block on NHS progress
Better patient outcomes are at risk in the backlash against American tech
TL;DR
- The NHS is at risk of experiencing a backlash against American tech companies.
- This controversy could hinder improvements in patient outcomes.
- Advancements in healthcare technology are at stake.
- Concerns about American tech may slow down crucial progress for the NHS.